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Abstract 
Non-invasive identification of non-culprit lesions may improve preventive strategies for 
acute myocardial infarction (AMI). We assessed morphology, composition, and spatial 
distribution of non-culprit coronary plaques in patients with AMI by computed 
tomography angiography (CTA). Sixty-four patients with AMI underwent 64-slice CTA 
within 2 week after admission, and 162 symptomatic patients with stable angina pectoris 
(SAP) underwent CTA and stress myocardial perfusion imaging (MPI). Of these 226 
patients, 16 were excluded from analysis due to image artifacts. Mean number of 
non-culprit plaques per patient was 5.0 ± 2.6 in the AMI group (n = 60), 4.2 ± 2.6 in the 
SAP group with abnormal MPI (n = 67), and 1.1 ± 1.3 in the SAP group with normal MPI 
(n = 83) (p <0.01). Positive remodeling (PR) and low-attenuation plaques (LAP) (<30 
Hounsfield Units) were more frequently observed in the AMI group (1.9 ± 1.8) than in the 
SAP groups (0.6 ± 0.9 in abnormal MPI, 0.2 ± 0.4 in normal MPI) (p <0.01). Within the 
AMI group, PR and LAP was present significantly more frequently in patients with 
metabolic syndrome than in those without (2.6 ± 2.2 vs. 1.4 ± 1.4; p = 0.03) and was 
significantly more frequently distributed in the proximal segments of the left anterior 
descending artery (p <0.01). In conclusion, 64-slice CTA may provide promising 
information on preventive strategies by identifying non-culprit plaque morphology and 
zones at high risk for future events. 
 
Key Words: computed tomography angiography; low-attenuation plaque; positive 
remodeling; perfusion 
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The recent advent of multidetector computed tomography angiography (CTA) has 
greatly improved image quality and may allow more precise evaluation of coronary 
stenosis and plaque morphology.
1,2
 Previous CTA studies introduced the concept of 
noninvasive detection and characterization of coronary atherosclerotic lesions in patients 
with AMI and stable angina pectoris (SAP)
3
 and identified differences in lesion 
morphology and plaque composition between culprit lesions in patients with acute 
coronary syndrome (ACS) and stable lesions in patients with ACS or SAP.
4
 Recently, 
Motoyama et al. demonstrated that CT characteristics of culprit lesions in ACS included 
positive remodeling (PR) and low-attenuation plaques (LAP)
5
 and that patients with these 
2 plaque characteristics on CTA were at a higher risk of ACS developing during 
follow-up when compared with patients having lesions without these characteristics.
6
 We 
therefore hypothesized that positively remodeled plaques with LAP in non-culprit lesions, 
favoring a propensity to rapidly progress to a culprit lesion or rupture, might be more 
frequently observed in AMI patients within the proximal third of the major epicardial 
coronary arteries. To investigate this hypothesis, we examined whether 64-slice CTA can 
noninvasively assess the spatial distribution, morphology, and composition of non-culprit 
lesions in patients with AMI in comparison with stable lesions in patients with SAP. 
Methods 
We studied a prospective but nonconsecutive series of 226 patients who underwent 
64-slice CTA from September 2006 to December 2007. The study population consisted 
of 64 patients with AMI and 162 symptomatic patients with suspected coronary artery 
disease (CAD) who underwent stress myocardial perfusion imaging (MPI). In these 162 
patients, stress MPI was positive in 72 patients and negative in 90 patients. AMI was 
defined as follows: 1) chest pain >30 minutes in duration with presentation within 12 
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hours after the onset of symptoms; 2) ST-segment elevation >0.1 mV within 2 contiguous 
electrocardiograph leads; 3) elevated creatine kinase-MB isoenzymes within 12 hours of 
chest pain. AMI patients underwent 64-slice CTA within 2 week after successful primary 
stenting. SAP was defined as no change in frequency, duration, or intensity of chest pain 
within 4 weeks in patients in sinus heart rhythm and without previous myocardial 
infarction, previous PCI or coronary bypass surgery, and unstable angina. 
Of the 226 patients, 16 patients (4 in the AMI group, 5 in the SAP with abnormal 
MPI group, and 7 in the SAP with normal MPI group) were excluded from analysis due 
to image artifacts that made assessment of the entire coronary anatomy impossible on 
CTA images. The remaining 210 patients (AMI group, n = 60; SAP with abnormal MPI 
group, n = 67; SAP with normal MPI group, n = 83) represent the population of this study. 
Written informed consent was obtained from all patients, and the study protocol was 
approved by our institutional review board. 
Scanning was performed with a 64-slice CT scanner (Aquilion 64; Toshiba Medical 
Systems Corporation, Otawara, Japan). According to a previous published protocol,
2
 
images were acquired with 64 × 0.5-mm slice collimation, gantry rotation speed of 400 
ms/rotation, table feed of 6.4 mm/gantry rotation, tube energy of 120 kV, and an effective 
tube current of 400 mAs. The CT dose index volume and dose-length product of this scan 
protocol were 75.2 mGy and 1.10 Gy•cm, respectively, and corresponded to an 
approximate mean radiation dose of 15 mSv. A volume of 60 ml of contrast agent 
(Iopamidol 370, 370 mgI/ml; Schering AG, Berlin, Germany) was injected intravenously 
at a rate of 4 ml/s. Patients were given oral metoprolol 20-40 mg 1 hour before the 
scheduled scan if their heart rate was >65 beats/min, and all patients were given 
sublingual nitroglycerin 0.3 mg 5 minutes before the scan. 
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Analysis of the scans was performed using a ZIOSTATION workstation (ZIOSOFT 
Inc., Tokyo, Japan). Images were initially reconstructed at 75% of the cardiac cycle with 
a slice thickness of 0.5 mm at an increment of 0.3 mm. In the case of motion artifacts, 
additional reconstructions were made at different time points of the R-R interval. Each 
scan was analyzed independently by 2 experienced readers who were blinded to the 
results of the stress Tl-201 SPECT. 
The image display settings were modified on an individual basis to accommodate 
differences in contrast enhancement or image noise in some patients. The individually 
optimized window width (between 600 and 900 HU [Hounsfield Units]) and level 
(between 100 and 250 HU) settings were maintained for each of the measurements.
7
 
Coronary atherosclerotic plaque was visually classified as follows: 1) non-calcified 
plaque was defined as any discernible structure that could be assigned to the coronary 
artery wall, with CT attenuation below that of the contrast-enhanced coronary lumen but 
above that of the surrounding connective tissue/epicardial fat
7,8
; 2) calcified plaque was 
defined as any structure with CT attenuation of >130 HU that could be visualized 
separately from the contrast-enhanced coronary lumen (either because it was embedded 
within non-calcified plaque or because its density was above that of the 
contrast-enhanced lumen). Spotty calcification was defined when <3 mm in size on 
curved multi-planar reformation and 1-sided on cross-sectional images
5
; 3) mixed plaque 
was defined as plaque with non-calcified and calcified elements present; 4) LAP was 
defined as plaque with low CT density (<30 HU).
6
 The remodeling index (RI) was 
calculated by dividing the lesion diameter at the plaque site of maximum luminal 
narrowing by the reference diameter (proximal to the lesion in a normal-appearing vessel 
segment). PR was defined as a RI of >1.10. We used the coronary map modified from the 
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Bypass Angioplasty Revascularization Investigation (BARI).
9
 Proximal segments of 
coronary plaque location included #1 proximal right coronary artery (RCA), #12 
proximal left anterior descending artery (LAD), and  #18 proximal left circumflex (LC). 
Middle segments included #2 mid RCA, #13 Mid LAD, #15 diagonal 1 branches, #19 
mid LC, and #20 obtuse marginal 1. Distal segments included #3 distal RCA, #4 
posterior descending, #6 posterior lateral segment, #14 distal LAD, #16 diagonal 2 
branches, #19a distal LCx, and #21 obtuse marginal 2. 
Tl-201 SPECT was performed within 1 week of the CTA. Beta-blockers, calcium 
channel blockers, and nitrates were discontinued for 24-48 hours before the test. 
Adenosine was administered intravenously to all patients at 0.14 mg/kg/min for 6 
minutes, and a dose of 111 MBq of Tl-201 was injected 3 minutes into the infusion. ECG 
and blood pressure were monitored before, throughout, and after the infusion. The initial 
image was obtained in the supine position at 5 minutes after the Tl-201 injection, and a 
delayed image was obtained 4 hours later.  
SPECT was performed using a double-detector system (PICKER PRISM 2000XP; 
Shimadzu Corporation, Kyoto, Japan) equipped with a low-energy, high-resolution 
collimator according to a previous published protocol.
2
 SPECT images were assessed 
using a 17-segment model.
10 
Stress and delayed images were independently analyzed by 
2 nuclear medicine physicians who were blinded to the CTA data. Visual grading was 
defined as normal (no perfusion defects) or abnormal (stress perfusion defects with 
redistribution). 
Hypertension was defined as blood pressure at rest ≥140/90 mmHg or use of 
antihypertensive medication. Hyperlipidemia was defined as total fasting serum 
cholesterol ≥200 mg/dl or serum triglycerides ≥150 mg/dl or use of antihyperlipidemic 
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medication. The revised National Cholesterol Education Program criteria
11
 define 
metabolic syndrome as the presence of any 3 of the following 5 traits: 1) the cut point of 
waist circumference was modified for Japanese as ≥90 cm in men and ≥80 cm in women 
according to the recommendation by the International Diabetes Federation,
12
 2) blood 
pressure ≥130/85 mmHg or drug treatment for elevated blood pressure, 3) serum 
triglycerides ≥150 mg/dl or drug treatment for elevated triglycerides, 4) high-density 
lipoprotein (HDL) cholesterol <40 mg/dl in men and <50 mg/dl in women or drug 
treatment for low HDL-C, 5) fasting glucose ≥100 mg/dl or drug treatment for elevated 
blood glucose. 
All data are expressed as the mean ± SD or median and interquartile range. 
Comparisons of categorical variables between groups were performed by the chi-square 
test or Fisher’s exact test. Comparisons of continuous variables were analyzed by 
one-way analysis of variance or Kruskal-Wallis test. All probability values are 
considered significant when <0.05. 
Results 
Baseline clinical characteristics of the patients are summarized in Table 1, and 
characteristics of non-culprit lesions in AMI are presented in Figure 1. Of the 300 
plaques identified in the AMI group, 153 (51%) plaques were classified as non-calcified, 
72 (24%) as mixed, and 75 (25%) as calcified. Of the 281 plaques identified in the SAP 
group with abnormal MPI, 74 (26%) plaques were classified as non-calcified, 60 (22%) 
as mixed, and 147 (52%) as calcified. In the SAP group with normal MPI, of the 91 
plaques identified, 50 (55%) were classified as non-calcified, 17 (18%) as mixed, and 25 
(27%) as calcified. The mean number of coronary plaques per patient was 5.0 ± 2.6 in the 
AMI group, 4.2 ± 2.6 in the SAP group with abnormal MPI, and 1.1 ± 1.3 in the SAP 
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group with normal MPI (p <0.01) (Figure 2). The mean number of PR and LAP per 
patient was 1.9 ± 1.8 in the AMI group, 0.6 ± 0.9 in the SAP group with abnormal MPI, 
and 0.2 ± 0.4 in the SAP group with normal MPI (p <0.01). Of these PR and LAP, spotty 
calcification was observed significantly more frequently in the AMI group (0.8 ± 1.2) 
than in the SAP group with abnormal MPI (0.4 ± 0.7) and with normal MPI (0.03 ± 0.2) 
(p <0.01). In the AMI group, the number of PR and LAP was significantly higher in 
patients with metabolic syndrome than in those without, whereas there was no difference 
in the total number of plaques between these two groups (Figure 3). 
Spatial distribution of non-culprit coronary plaques in AMI patients on CTA images 
is shown in Figure 4. In the LAD and LCx coronary arteries, non-calcified, calcified, and 
mixed plaques were more frequently distributed in the proximal segments, whereas there 
were no differences in distribution of non-calcified, calcified, and mixed plaques in the 
RCA. PR and LAP were more frequently distributed in the proximal segments of the 
LAD, whereas there were no differences in distribution of PR and LAP in the RCA and 
LC. In the left main (LM) coronary artery, 8 (13%) plaques were classified as 
non-calcified, 3 (5%) as mixed, 3 (5%) as calcified, and 4 (7%) as PR and LAP. Culprit 
lesions in the LAD were more frequently distributed in the proximal segment (proximal 
20 [55%], mid 13 [36%], distal 3 [9%], p < 0.01), whereas there were no differences in 
distribution of culprit lesions in the RCA (proximal 6 [30%], mid 8 [40%], distal 6 [30%], 
p = 0.48) and LC (proximal 2 [50%], mid 2 [50%], distal 0, p = 1.0). 
Discussion 
The major important findings of the present study are as follows. First, CT-based 
plaque burden is higher in AMI patients and SAP patients with abnormal MPI than in 
SAP patients with normal MPI. Non-culprit coronary plaque appearance mimics that of 
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culprit lesions. Second, in the AMI patients, the number of noncalcified plaques with low 
CT density and positive remodeling was significantly higher in patients with metabolic 
syndrome than in those without the syndrome, and these plaques were more frequently 
distributed in the proximal segments of the LAD. Therefore, 64-slice CTA may 
noninvasively provide promising information on preventive strategies by facilitating 
identification of coronary plaque morphology and zones at high risk for future events in 
AMI patients. 
Approximately 6% of PCI patients will have clinical plaque progression requiring 
non-target lesion PCI by 1 year, and greater coronary artery disease burden confers a 
significantly higher risk for clinical plaque progression.
13
 With its higher X-ray output 
and faster tube rotation, 64-slice CTA results in high-quality, motion-free, and isotropic 
image quality.
1
 In the present study, we showed that on CTA images, a significantly 
greater number of coronary plaques in non-culprit lesions is observed in AMI patients 
than in SAP patients with normal MPI. Non-calcified, mixed, and PR and LAP were 
more significantly observed in AMI patients than in SAP patients. Leber et al. found that 
non-calcified plaques contribute to a higher degree to total plaque burden in AMI than in 
SAP.
3
 In addition, 64-slice CTA enables the visualization of lipid cores and spotty 
calcifications that are frequently associated with plaque ruptures.
7
 Positive remodeling 
and lipid cores are associated with plaque vulnerability in both histopathologic
14
 and 
intravascular ultrasound (IVUS) studies.
15,16
 Patients demonstrating positively 
remodeled coronary segments with LAP on CTA are at a higher risk of ACS developing 
over time.
6
 The present study suggests that all 3 major coronary arteries in patients with 
AMI are extensively diseased and have multiple plaques that could potentially cause 
another occurrence of ACS, although the natural course of this plaque development and 
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disruption has not yet been clearly established. 
Recent studies have demonstrated that metabolic syndrome is associated with an 
increasing risk of cardiovascular disease.
17
 Furthermore, IVUS study has shown that 
metabolic syndrome is associated with lipid-rich plaques that contribute to the increasing 
risk of plaque vulnerability.
18
 In the present study, within the AMI group, the number of 
PR and LAP was significantly higher in patients with metabolic syndrome than in those 
without the syndrome. This finding might explain the mechanism of metabolic syndrome 
contributing to the increased risk of cardiovascular events. 
A previous study examined the geographical distribution of occlusive thromboses 
throughout the coronary tree and showed that such occlusions are clustered within the 
proximal portions of the major epicardial arteries.
19
 In the present study, we observed 
culprit lesions and PR and LAP of non-culprit lesions in the proximal LAD of AMI 
patients more frequently than in other sites on CTA. The use of optical coherence 
tomography (OCT) revealed thin-capped fibroatheromas (TCFAs) in the proximal left 
coronary artery more frequently than in other sites.
20
 The frequency of PR and LAP we 
observed is very similar to that of the TCFAs reported in the previous OCT study. We 
have shown that CTA can noninvasively reveal the PR and LAP in non-culprit lesions 
favoring a propensity to rapidly progress to a culprit lesion or rupture. 
The largest prognostic study with thallium-201 SPECT showed a cardiac mortality 
rate of 0.42%/y in patients with normal scans and 2.1%/y in patients with abnormal 
scans.
21
 However it is not clear how many of these patients had vulnerable coronary 
plaques leading to ACS and cardiac events. In the present study, we showed that the 
number of coronary plaques in non-culprit lesions is observed significantly less 
frequently in SAP patients with normal MPI than in AMI patients. Specifically, calcified 
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plaques were more significantly observed in SAP patients with abnormal MPI than in 
AMI patients. The prevalence of CAD in SAP patients with normal MPI was also small, 
in concordance with 14 published reports comprising more than 12000 patients that 
showed normal stress SPECT 
99m
Tc-sestamibi images to be associated with an average 
annual hard event rate of 0.6%.
22
  
The advantage of CTA over that of invasive modalities such as IVUS, angioscopy, 
and OCT is its noninvasive character. We noninvasively identified differences in plaque 
morphology and composition between non-culprit lesions in patients with AMI and SAP 
on CT images. The ability to noninvasively identify PR and LAP has major clinical 
implications because ACS represents the leading cause of morbidity and mortality 
worldwide. Furthermore, CTA contributes important morphologic information in 
addition to evaluating the functional significance of coronary stenosis with stress MPI. If 
confirmed by further studies, secondary prevention should be considered with intensive 
lipid-lowering therapy such as statin use in patients with identified PR and LAP. Indeed, 
early initiation of statin treatment following AMI is associated with a lower 1-year 
mortality rate.
23
 
The current study has some limitations. First, radiation dose levels to the patient are 
relatively high when stress MPI and CTA are combined. It is expected that radiation 
exposure will be significantly reduced with the use of a modified protocol that includes 
ECG-pulsing. Second, the threshold of 30 HU for the LAP was limited as the CT density 
of non-calcified plaques depends on the image quality and intraluminal contrast 
attenuation, and no correlation to IVUS was performed in the present study. 
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Figure Legends 
  
Figure 1. Sixty-four-slice CTA images of non-culprit lesions present in the three major 
coronary arteries in a 47-year-old man with inferior AMI. (A) Non-calcified plaques in 
the proximal and mid RCA and coronary stent in the culprit lesion in the distal RCA. (B) 
Coronary plaques in the proximal and mid LAD. (C) Non-calcified plaque in the mid LC. 
(D)(E) Cross-sectional images showed mild stenosis with normal CT values. (F) 
Cross-sectional image of plaque with low CT value (16 HU) and positive remodeling 
(RI: 1.10) in the proximal LAD. (G) Cross-sectional image of non-calcified plaque with 
low CT value (0 HU) in the mid LAD. (H) Cross-sectional image from the proximal LC 
showed low CT value (15 HU) and positive remodeling (RI: 1.05). (I) Cross-sectional 
image of non-calcified plaque in the distal LC. 
 
Figure 2. Mean number of the coronary plaques in the non-culprit segments of the AMI 
and SAP patients. AMI = acute myocardial infarction; SAP = stable angina pectoris; MPI 
= myocardial perfusion imaging; PR = positive remodeling; LAP = low-attenuation 
plaques. 
 
Figure 3. Mean total number of coronary plaques and PR and LAP in the non-culprit 
segments of the AMI patients with and without metabolic syndrome. Met S = metabolic 
syndrome; PR = positive remodeling; LAP = low-attenuation plaques. 
 
Figure 4. Spatial distribution of the coronary plaques in the non-culprit segments of the 
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AMI patients. (A) Non-calcified plaques, (B) Calcified plaques, (C) PR and LAP, and 
(D) Mixed plaques. RCA = right coronary artery; LAD = left anterior descending artery; 
LC = left circumflex artery; PR = positive remodeling; LAP = low-attenuation plaques. 
 
  
Table 1. Clinical Characteristics of the Patients 
 
Variable 
AMI 
 
(n = 60) 
SAP with 
abnormal MPI 
(n = 67) 
SAP with 
normal MPI 
(n = 83) 
p 
Value 
Age (years) 64±10 67±12 66±10 0.35 
Male/female 49/11 40/12 49/34 <0.01 
Hypertension  33 (55%) 37 (56%) 43 (52%) 0.85 
Hyperlipidemia  30 (50%) 36 (54%) 40 (48%) 0.83 
Diabetes mellitus 25 (42%) 30 (45%) 27 (33%) 0.41 
Smoker  35 (58%) 34 (51%) 35 (43%) 0.23 
Body mass index (kg/m
2
) 24.7 
(22.0-26.3) 
24.4 
(22.3-26.7) 
23.7 
(20.7-26.2) 
0.50 
Culprit coronary artery 
Right 
Left anterior descending 
Left circumflex 
 
20 
36 
4 
 
21 
43 
3 
- 
0.69 
AMI = acute myocardial infarction 
SAP = stable angina pectoris 
MPI = myocardial perfusion imaging 
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